Parkinson's Disease

Parkinson's disease is a brain disorder. It occurs when certain nerve cells (neurons) in a part of the brain called the substantia nigra die or become impaired. When approximately 80 percent of neurons are damaged, the symptoms of Parkinson's disease appear. Parkinson's disease affects 1 in 100 people over the age of 60, with the average age of onset being 60 years. The risk of developing Parkinson's disease increases with age. In the United States, it is estimated that 60,000 new cases of Parkinson's disease are diagnosed each year, with 1.5 million Americans currently living with the disease.

Overview

Feature Articles

Latest Parkinson's Disease News and Research

'Silent' wave of neurological consequences may be on its way due to COVID-19

'Silent' wave of neurological consequences may be on its way due to COVID-19

Parkinson's disease diagnosed after SARS-CoV-2

Parkinson's disease diagnosed after SARS-CoV-2

Existence of brain-first and body-first Parkinson’s disease subtypes

Existence of brain-first and body-first Parkinson’s disease subtypes

New $6.2 million study seeks to define molecular linkages between aging and Parkinson's

New $6.2 million study seeks to define molecular linkages between aging and Parkinson's

Innovative approach for identifying new molecules to help track progression of Parkinson's

Innovative approach for identifying new molecules to help track progression of Parkinson's

Biomarker for earlier diagnosis of neurodegenerative diseases detected in the eye

Biomarker for earlier diagnosis of neurodegenerative diseases detected in the eye

Astrocytes are essential for blood-brain barrier health, shows study

Astrocytes are essential for blood-brain barrier health, shows study

Researchers describe details of protein linked to genetically inherited Parkinson's disease

Researchers describe details of protein linked to genetically inherited Parkinson's disease

Smart drug delivery system may help treat spinal cord injuries, neurological disorders

Smart drug delivery system may help treat spinal cord injuries, neurological disorders

NTU-incubated start-up plans clinical trial of new slow-release pill for Parkinson’s disease

NTU-incubated start-up plans clinical trial of new slow-release pill for Parkinson’s disease

Physical exercise protocol can mitigate the severity of Parkinson's disease

Physical exercise protocol can mitigate the severity of Parkinson's disease

LRRK2 enzyme suppresses protein synthesis in Parkinson’s disease

LRRK2 enzyme suppresses protein synthesis in Parkinson’s disease

MSU engineers secure $3.4 million to develop diamond devices to detect Parkinson's

MSU engineers secure $3.4 million to develop diamond devices to detect Parkinson's

Scientists elucidate cause for Parkinson's disease and identify potential treatments

Scientists elucidate cause for Parkinson's disease and identify potential treatments

New radio-frequency-based system to monitor a person's sleep postures

New radio-frequency-based system to monitor a person's sleep postures

Parkinson's disease drug may improve vision in patients with age-related macular degeneration

Parkinson's disease drug may improve vision in patients with age-related macular degeneration

Microglia-targeting nanotherapeutics for treatment of neurodegenerative disorders

Microglia-targeting nanotherapeutics for treatment of neurodegenerative disorders

New dietary intervention improves pain and other symptoms in veterans with Gulf War Illness

New dietary intervention improves pain and other symptoms in veterans with Gulf War Illness

Massive cellular energy audit identifies genes that drive energy production, consumption

Massive cellular energy audit identifies genes that drive energy production, consumption

Study may lead to new treatments for neurodegenerative diseases

Study may lead to new treatments for neurodegenerative diseases